by Livio Andrea Acerbo November 26, 2025 There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests Uncategorized In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal. Post navigation « Trump’s Peace Plan for Ukraine Sparks Debate Amid Russia’s Ongoing Assault on Kyiv – 11/26/2025, 8:29:28 AMCampbell’s promises its soups are not made with 3D printed meat » Related Posts EU Green Deal Progress Report: Only 32 of 154 Targets on Track, JRC Warns May 21, 2026: Analyzing Trump’s Landmark Multitrillion-Dollar Policy EU Locks In 90% Emissions Cut by 2040: What It Means for Business, Finance, and the Green Transition Privacy · Cookies · Terms We use essential cookies and, only with your consent, analytics cookies. Read our Cookie Policy. Reject Accept
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.